Safra Taşı Risk Faktörleri ve Korunma Yöntemleri

Peery AF, Crockett SD, Barritt AS, Dellon ES, Eluri S, Gangarosa LM, et al. Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States. Gastroenterology [Internet]. 2015 Dec;149(7):1731-1741.e3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26327134

Carulli N, Ponz De Leon M, Zironi F, Pinetti A, Smerieri A, Iori R, et al. Hepatic cholesterol and bile acid metabolism in subjects with gallstones: comparative effects of short erm feeding of chenodeoxycholic and ursodeoxycholic acid. J Lipid Res [Internet]. 1980 Jan;21(1):35–43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7354253

Everhart JE, Khare M, Hill M, Maurer KR. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology [Internet]. 1999 Sep;117(3):632–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10464139

Aerts R, Penninckx F. The burden of gallstone disease in Europe. Aliment Pharmacol Ther [Internet]. 2003 Nov;18 Suppl 3:49–53. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14531741

Völzke H, Baumeister SE, Alte D, Hoffmann W, Schwahn C, Simon P, et al. Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence. Digestion [Internet]. 2005;71(2):97–105. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15775677

Cirillo DJ, Wallace RB, Rodabough RJ, Greenland P, LaCroix AZ, Limacher MC, et al. Effect of estrogen therapy on gallbladder disease. JAMA [Internet]. 2005 Jan 19;293(3):330–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15657326

Attili AF, Carulli N, Roda E, Barbara B, Capocaccia L, Menotti A, et al. Epidemiology of gallstone disease in Italy: prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.). Am J Epidemiol [Internet]. 1995 Jan 15;141(2):158–65. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7817971

Galyani Moghaddam T, Fakheri H, Abdi R, Khosh Bavar Rostami F, Bari Z. The incidence and outcome of pregnancy-related biliary sludge/stones and potential risk factors. Arch Iran Med [Internet]. 2013 Jan;16(1):12–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23273228

Racine A, Bijon A, Fournier A, Mesrine S, Clavel-Chapelon F, Carbonnel F, et al. Menopausal hormone therapy and risk of cholecystectomy: a prospective study based on the French E3N cohort. CMAJ [Internet]. 2013 Apr 16;185(7):555–61. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23509128

Everhart JE, Yeh F, Lee ET, Hill MC, Fabsitz R, Howard B V, et al. Prevalence of gallbladder disease in American Indian populations: findings from the Strong Heart Study. Hepatology [Internet]. 2002 Jun;35(6):1507–12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12029637

Gilat T, Feldman C, Halpern Z, Dan M, Bar-Meir S. An increased familial frequency of gallstones. Gastroenterology [Internet]. 1983 Feb;84(2):242–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6848404

Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver [Internet]. 2012 Apr;6(2):172–87. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22570746

Sarin SK, Negi VS, Dewan R, Sasan S, Saraya A. High familial prevalence of gallstones in the first-degree relatives of gallstone patients. Hepatology [Internet]. 1995 Jul;22(1):138–41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7601405

Buch S, Schafmayer C, Völzke H, Becker C, Franke A, von Eller-Eberstein H, et al. A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease. Nat Genet [Internet]. 2007 Aug;39(8):995–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17632509

Sichieri R, Everhart JE, Roth HP. Low incidence of hospitalization with gallbladder disease among blacks in the United States. Am J Epidemiol [Internet]. 1990 May;131(5):826–35. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1010661

Nomura H, Kashiwagi S, Hayashi J, Kajiyama W, Ikematsu H, Noguchi A, et al. Prevalence of gallstone disease in a general population of Okinawa, Japan. Am J Epidemiol [Internet]. 1988 Sep;128(3):598–605. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3046339

Brett M, Barker DJ. The world distribution of gallstones. Int J Epidemiol [Internet]. 1976 Dec;5(4):335–41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1010661

Di Ciaula A, Molina-Molina E, Bonfrate L, Wang DQ-H, Dumitrascu DL, Portincasa P. Gastrointestinal defects in gallstone and cholecystectomized patients. Eur J Clin Invest [Internet]. 2019 Mar;49(3):e13066. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30592298

Acalovschi M. Cholesterol gallstones: from epidemiology to prevention. Postgrad Med J [Internet]. 2001 Apr;77(906):221–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11264482

Tsai C-J, Leitzmann MF, Willett WC, Giovannucci EL. Long-chain saturated fatty acids consumption and risk of gallstone disease among men. Ann Surg [Internet]. 2008 Jan;247(1):95–103. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18156928

Tsunoda K, Shirai Y, Hatakeyama K. Prevalence of cholesterol gallstones positively correlates with per capita daily calorie intake. Hepatogastroenterology [Internet]. 2004;51(59):1271–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15362730

Tsai C-J, Leitzmann MF, Willett WC, Giovannucci EL. Dietary carbohydrates and glycaemic load and the incidence of symptomatic gall stone disease in men. Gut [Internet]. 2005 Jun;54(6):823–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15888792

Misciagna G, Centonze S, Leoci C, Guerra V, Cisternino AM, Ceo R, et al. Diet, physical activity, and gallstones--a population-based, case-control study in southern Italy. Am J Clin Nutr [Internet]. 1999 Jan;69(1):120–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9925133

Katsika D, Tuvblad C, Einarsson C, Lichtenstein P, Marschall H-U. Body mass index, alcohol, tobacco and symptomatic gallstone disease: a Swedish twin study. J Intern Med [Internet]. 2007 Nov;262(5):581–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17908165

Stender S, Nordestgaard BG, Tybjaerg-Hansen A. Elevated body mass index as a causal risk factor for symptomatic gallstone disease: a Mendelian randomization study. Hepatology [Internet]. 2013 Dec;58(6):2133–41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23775818

Stampfer MJ, Maclure KM, Colditz GA, Manson JE, Willett WC. Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr [Internet]. 1992 Mar;55(3):652–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1550039

Amaral JF, Thompson WR. Gallbladder disease in the morbidly obese. Am J Surg [Internet]. 1985 Apr;149(4):551–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3310613

Li VKM, Pulido N, Fajnwaks P, Szomstein S, Rosenthal R, Martinez-Duartez P. Predictors of gallstone formation after bariatric surgery: a multivariate analysis of risk factors comparing gastric bypass, gastric banding, and sleeve gastrectomy. Surg Endosc [Internet]. 2009 Jul;23(7):1640–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19057954

Csendes A, Csendes P, Orellana O, Cuneo N, Figueroa M, Martinez G. Patients Remain at High Risk of Gallstones Development Late (10 y) After Sleeve Gastrectomy? Surg Laparosc Endosc Percutan Tech [Internet]. 2019 Dec;29(6):451–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31318846

Johansson K, Sundström J, Marcus C, Hemmingsson E, Neovius M. Risk of symptomatic gallstones and cholecystectomy after a very-low-calorie diet or low-calorie diet in a commercial weight loss program: 1-year matched cohort study. Int J Obes [Internet]. 2014 Feb 22;38(2):279–84. Available from: https://www.nature.com/articles/ijo201383

Syngal S, Coakley EH, Willett WC, Byers T, Williamson DF, Colditz GA. Long-term weight patterns and risk for cholecystectomy in women. Ann Intern Med [Internet]. 1999 Mar 16;130(6):471–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10075614

Tsai C-J, Leitzmann MF, Willett WC, Giovannucci EL. Weight cycling and risk of gallstone disease in men. Arch Intern Med [Internet]. 2006 Nov 27;166(21):2369–74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17130391

Ahmed MH, Barakat S, Almobarak AO. The association between renal stone disease and cholesterol gallstones: the easy to believe and not hard to retrieve theory of the metabolic syndrome. Ren Fail [Internet]. 2014 Jul;36(6):957–62. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24678942

Al-Azzawi HH, Mathur A, Lu D, Swartz-Basile DA, Nakeeb A, Pitt HA. Resistin-like molecule alpha reduces gallbladder optimal tension. J Gastrointest Surg [Internet]. 2007 Jan;11(1):95–100. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17390194

Hahm JS, Park JY, Park KG, Ahn YH, Lee MH, Park KN. Gallbladder motility in diabetes mellitus using real time ultrasonography. Am J Gastroenterol [Internet]. 1996 Nov;91(11):2391–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8931423

Batajoo H, Hazra NK. Analysis of serum lipid profile in cholelithiasis patients. J Nepal Health Res Counc [Internet]. 2013 Jan;11(23):53–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23787527

De Santis A, Attili AF, Ginanni Corradini S, Scafato E, Cantagalli A, De Luca C, et al. Gallstones and diabetes: a case-control study in a free-living population sample. Hepatology [Internet]. 1997 Apr;25(4):787–90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9096577

Ruhl CE, Everhart JE. Association of diabetes, serum insulin, and C-peptide with gallbladder disease. Hepatology [Internet]. 2000 Feb;31(2):299–303. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10655249

Biddinger SB, Haas JT, Yu BB, Bezy O, Jing E, Zhang W, et al. Hepatic insulin resistance directly promotes formation of cholesterol gallstones. Nat Med [Internet]. 2008 Jul;14(7):778–82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10655249

Walcher T, Haenle MM, Mason RA, Koenig W, Imhof A, Kratzer W, et al. The effect of alcohol, tobacco and caffeine consumption and vegetarian diet on gallstone prevalence. Eur J Gastroenterol Hepatol [Internet]. 2010 Nov;22(11):1345–51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20802339

Murray FE, Logan RF, Hannaford PC, Kay CR. Cigarette smoking and parity as risk factors for the development of symptomatic gall bladder disease in women: results of the Royal College of General Practitioners’ oral contraception study. Gut [Internet]. 1994 Jan;35(1):107–11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8307429

Pixley F, Mann J. Dietary factors in the aetiology of gall stones: a case control study. Gut [Internet]. 1988 Nov;29(11):1511–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3209107

Sahi T, Paffenbarger RS, Hsieh CC, Lee IM. Body mass index, cigarette smoking, and other characteristics as predictors of self-reported, physician-diagnosed gallbladder disease in male college alumni. Am J Epidemiol [Internet]. 1998 Apr 1;147(7):644–51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9554603

Caroli-Bosc FX, Le Gall P, Pugliese P, Delabre B, Caroli-Bosc C, Demarquay JF, et al. Role of fibrates and HMG-CoA reductase inhibitors in gallstone formation: epidemiological study in an unselected population. Dig Dis Sci [Internet]. 2001 Mar;46(3):540–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11318529

Teramoto T, Abe K, Taneyama T. Safety and efficacy of long-term combination therapy with bezafibrate and ezetimibe in patients with dyslipidemia in the prospective, observational J-COMPATIBLE study. Cardiovasc Diabetol [Internet]. 2013 Nov 6;12:163. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24195788

Ståhlberg D, Reihnér E, Rudling M, Berglund L, Einarsson K, Angelin B. Influence of bezafibrate on hepatic cholesterol metabolism in gallstone patients: reduced activity of cholesterol 7 alpha-hydroxylase. Hepatology [Internet]. 1995 Apr;21(4):1025–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7705775

Shiffman ML, Keith FB, Moore EW. Pathogenesis of ceftriaxone-associated biliary sludge. In vitro studies of calcium-ceftriaxone binding and solubility. Gastroenterology [Internet]. 1990 Dec;99(6):1772–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2227290

Arvidsson A, Alván G, Angelin B, Borgå O, Nord CE. Ceftriaxone: renal and biliary excretion and effect on the colon microflora. J Antimicrob Chemother [Internet]. 1982 Sep;10(3):207–15. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6292158

Hussaini SH, Murphy GM, Kennedy C, Besser GM, Wass JA, Dowling RH. The role of bile composition and physical chemistry in the pathogenesis of octreotide-associated gallbladder stones. Gastroenterology [Internet]. 1994 Nov;107(5):1503–13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7926514

Ezzat S, Snyder PJ, Young WF, Boyajy LD, Newman C, Klibanski A, et al. Octreotide treatment of acromegaly. A randomized, multicenter study. Ann Intern Med [Internet]. 1992 Nov 1;117(9):711–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1416572

Newman CB, Melmed S, Snyder PJ, Young WF, Boyajy LD, Levy R, et al. Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center study. J Clin Endocrinol Metab [Internet]. 1995 Sep;80(9):2768–75. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7673422

Henriksson P, Einarsson K, Eriksson A, Kelter U, Angelin B. Estrogen-induced gallstone formation in males. Relation to changes in serum and biliary lipids during hormonal treatment of prostatic carcinoma. J Clin Invest [Internet]. 1989 Sep;84(3):811–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2760214

Strom BL, Tamragouri RN, Morse ML, Lazar EL, West SL, Stolley PD, et al. Oral contraceptives and other risk factors for gallbladder disease. Clin Pharmacol Ther [Internet]. 1986 Mar;39(3):335–41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3948473

Scragg RK, McMichael AJ, Seamark RF. Oral contraceptives, pregnancy, and endogenous oestrogen in gall stone disease--a case-control study. Br Med J (Clin Res Ed) [Internet]. 1984 Jun 16;288(6433):1795–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6428548

Thijs C, Leffers P, Knipschild P. Oral contraceptive use and the occurrence of gallstone disease--a case-control study. Prev Med (Baltim) [Internet]. 1993 Jan;22(1):122–31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8475008

Thijs C, Knipschild P. Oral contraceptives and the risk of gallbladder disease: a meta-analysis. Am J Public Health [Internet]. 1993 Aug;83(8):1113–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8342719

Quigley EM, Marsh MN, Shaffer JL, Markin RS. Hepatobiliary complications of total parenteral nutrition. Gastroenterology [Internet]. 1993 Jan;104(1):286–301. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8419252

Nightingale JM, Lennard-Jones JE, Gertner DJ, Wood SR, Bartram CI. Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gall stones in patients with a short bowel. Gut [Internet]. 1992 Nov;33(11):1493–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1452074

Apstein MD, Dalecki-Chipperfield K. Spinal cord injury is a risk factor for gallstone disease. Gastroenterology [Internet]. 1987 Apr;92(4):966–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3557002

Rotter KP, Larraín CG. Gallstones in spinal cord injury (SCI): a late medical complication? Spinal Cord [Internet]. 2003 Feb;41(2):105–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12595873

Parente F, Pastore L, Bargiggia S, Cucino C, Greco S, Molteni M, et al. Incidence and risk factors for gallstones in patients with inflammatory bowel disease: a large case-control study. Hepatology [Internet]. 2007 May;45(5):1267–74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17464998

Fraquelli M, Losco A, Visentin S, Cesana BM, Pometta R, Colli A, et al. Gallstone disease and related risk factors in patients with Crohn disease: analysis of 330 consecutive cases. Arch Intern Med [Internet]. 2001 Oct 8;161(18):2201–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11575976

Brink MA, Slors JF, Keulemans YC, Mok KS, De Waart DR, Carey MC, et al. Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn’s disease. Gastroenterology [Internet]. 1999 Jun;116(6):1420–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10348826

Lapidus A, Bångstad M, Aström M, Muhrbeck O. The prevalence of gallstone disease in a defined cohort of patients with Crohn’s disease. Am J Gastroenterol [Internet]. 1999 May;94(5):1261–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10235204

Stender S, Frikke-Schmidt R, Nordestgaard BG, Tybjærg-Hansen A. Extreme bilirubin levels as a causal risk factor for symptomatic gallstone disease. JAMA Intern Med [Internet]. 2013 Jul 8;173(13):1222–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23753274

Wasmuth HE, Keppeler H, Herrmann U, Schirin-Sokhan R, Barker M, Lammert F. Coinheritance of Gilbert syndrome-associated UGT1A1 mutation increases gallstone risk in cystic fibrosis. Hepatology [Internet]. 2006 Apr;43(4):738–41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16557566

Conte D, Fraquelli M, Fornari F, Lodi L, Bodini P, Buscarini L. Close relation between cirrhosis and gallstones: cross-sectional and longitudinal survey. Arch Intern Med [Internet]. 1999 Jan 11;159(1):49–52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9892330

Buzaş C, Chira O, Mocan T, Acalovschi M. Comparative study of gallbladder motility in patients with chronic HCV hepatitis and with HCV cirrhosis. Rom J Intern Med [Internet]. 2011;49(1):37–44. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2202625

Alvaro D, Angelico M, Gandin C, Ginanni Corradini S, Capocaccia L. Physico-chemical factors predisposing to pigment gallstone formation in liver cirrhosis. J Hepatol [Internet]. 1990 Mar;10(2):228–34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2332595

Acalovschi M, Dumitraşcu DL, Csakany I. Gastric and gall bladder emptying of a mixed meal are not coordinated in liver cirrhosis--a simultaneous sonographic study. Gut [Internet]. 1997 Mar;40(3):412–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9135534

Stroffolini T, Sagnelli E, Mele A, Cottone C, Almasio PL, Italian Hospitals’ Collaborating Group. HCV infection is a risk factor for gallstone disease in liver cirrhosis: an Italian epidemiological survey. J Viral Hepat [Internet]. 2007 Sep;14(9):618–23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17697013

Acalovschi M, Buzas C, Radu C, Grigorescu M. Hepatitis C virus infection is a risk factor for gallstone disease: a prospective hospital-based study of patients with chronic viral C hepatitis. J Viral Hepat [Internet]. 2009 Dec;16(12):860–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19486279

Walcher T, Haenle MM, Kron M, Hay B, Mason RA, Walcher D, et al. Vitamin C supplement use may protect against gallstones: an observational study on a randomly selected population. BMC Gastroenterol [Internet]. 2009 Oct 8;9:74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19814821

Gustafsson U, Wang FH, Axelson M, Kallner A, Sahlin S, Einarsson K. The effect of vitamin C in high doses on plasma and biliary lipid composition in patients with cholesterol gallstones: prolongation of the nucleation time. Eur J Clin Invest [Internet]. 1997 May;27(5):387–91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9179545

Tsai C-J, Leitzmann MF, Willett WC, Giovannucci EL. Fruit and vegetable consumption and risk of cholecystectomy in women. Am J Med [Internet]. 2006 Sep;119(9):760–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16945611

Tsai C-J, Leitzmann MF, Willett WC, Giovannucci EL. The effect of long-term intake of cis unsaturated fats on the risk for gallstone disease in men: a prospective cohort study. Ann Intern Med [Internet]. 2004 Oct 5;141(7):514–22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15466768

Tsai C-J, Leitzmann MF, Hu FB, Willett WC, Giovannucci EL. A prospective cohort study of nut consumption and the risk of gallstone disease in men. Am J Epidemiol [Internet]. 2004 Nov 15;160(10):961–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15522852

Lander EM, Wertheim BC, Koch SM, Chen Z, Hsu C-H, Thomson CA. Vegetable protein intake is associated with lower gallbladder disease risk: Findings from the Women’s Health Initiative prospective cohort. Prev Med (Baltim) [Internet]. 2016 Jul;88:20–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27009631

Maclure KM, Hayes KC, Colditz GA, Stampfer MJ, Willett WC. Dietary predictors of symptom-associated gallstones in middle-aged women. Am J Clin Nutr [Internet]. 1990 Nov;52(5):916–22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2239768

Leitzmann MF, Willett WC, Rimm EB, Stampfer MJ, Spiegelman D, Colditz GA, et al. A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men. JAMA [Internet]. 1999 Jun 9;281(22):2106–12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10367821

Leitzmann MF, Stampfer MJ, Willett WC, Spiegelman D, Colditz GA, Giovannucci EL. Coffee intake is associated with lower risk of symptomatic gallstone disease in women. Gastroenterology [Internet]. 2002 Dec;123(6):1823–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12454839

Zhang Y-P, Li W-Q, Sun Y-L, Zhu R-T, Wang W-J. Systematic review with meta-analysis: coffee consumption and the risk of gallstone disease. Aliment Pharmacol Ther [Internet]. 2015 Sep;42(6):637–48. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26198295

Gaby AR. Nutritional approaches to prevention and treatment of gallstones. Altern Med Rev [Internet]. 2009 Sep;14(3):258–67. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19803550

European Association for the Study of the Liver (EASL). Electronic address: easloffice@easloffice.eu. EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones. J Hepatol [Internet]. 2016 Jul;65(1):146–81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27085810

Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation [Internet]. 2014 Jun 24;129(25 Suppl 2):S102-38. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24222017

Marks JW, Stein T, Schoenfield LJ. Natural history and treatment with ursodiol of gallstones formed during rapid loss of weight in man. Dig Dis Sci [Internet]. 1994 Sep;39(9):1981–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8423030

Leitzmann MF, Giovannucci EL, Rimm EB, Stampfer MJ, Spiegelman D, Wing AL, et al. The relation of physical activity to risk for symptomatic gallstone disease in men. Ann Intern Med [Internet]. 1998 Mar 15;128(6):417–25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9499324

Leitzmann MF, Rimm EB, Willett WC, Spiegelman D, Grodstein F, Stampfer MJ, et al. Recreational physical activity and the risk of cholecystectomy in women. N Engl J Med [Internet]. 1999 Sep 9;341(11):777–84. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10477775

Philipp E, Wilckens T, Friess E, Platte P, Pirke KM. Cholecystokinin, gastrin and stress hormone responses in marathon runners. Peptides [Internet]. 1992;13(1):125–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1320260

Watkins JB, Crawford ST, Sanders RA. Chronic voluntary exercise may alter hepatobiliary clearance of endogenous and exogenous chemicals in rats. Drug Metab Dispos [Internet]. 1994;22(4):537–43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7956727

Bodmer M, Brauchli YB, Krähenbühl S, Jick SS, Meier CR. Statin use and risk of gallstone disease followed by cholecystectomy. JAMA [Internet]. 2009 Nov 11;302(18):2001–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19903921

Erichsen R, Frøslev T, Lash TL, Pedersen L, Sørensen HT. Long-term statin use and the risk of gallstone disease: A population-based case-control study. Am J Epidemiol [Internet]. 2011 Jan 15;173(2):162–70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21084557

Sugerman HJ, Brewer WH, Shiffman ML, Brolin RE, Fobi MA, Linner JH, et al. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg [Internet]. 1995 Jan;169(1):91–6; discussion 96-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7818005

Shiffman ML, Kaplan GD, Brinkman-Kaplan V, Vickers FF. Prophylaxis against gallstone formation with ursodeoxycholic acid in patients participating in a very-low-calorie diet program. Ann Intern Med [Internet]. 1995 Jun 15;122(12):899–905. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7755224

Broomfield PH, Chopra R, Sheinbaum RC, Bonorris GG, Silverman A, Schoenfield LJ, et al. Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight. N Engl J Med [Internet]. 1988 Dec 15;319(24):1567–72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3200265

Zoli G, Ballinger A, Healy J, O’Donnell LJ, Clark M, Farthing MJ. Promotion of gallbladder emptying by intravenous aminoacids. Lancet (London, England) [Internet]. 1993 May 15;341(8855):1240–1. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8098392

Johnston SM, Murray KP, Martin SA, Fox-Talbot K, Lipsett PA, Lillemoe KD, et al. Iron deficiency enhances cholesterol gallstone formation. Surgery [Internet]. 1997 Aug;122(2):354–61; discussion 361-2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9288141